At the 34th EADV Congress, Almirall showcases 44 abstracts, two symposia, and an interactive space, highlighting lebrikizumab’s efficacy in atopic dermatitis, tildrakizumab in psoriasis, and tirbanibulin...
Almirall is a global biopharmaceutical company focused on medical dermatology. We collaborate with scientists and healthcare professionals to address patient needs through science to improve their...